Responses
Immunotherapy biomarkers
Original research
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.